Highlights

  • FY26 Revenue reached $29.2 million with 94% recurring revenue.
  • Recurring revenue increased 10%.
  • AI-enabled healthcare platforms remain central to product strategy.
  • Liquidity reached $5.5 million at 30 June 2026.

AI Healthcare Technology Platform

Beamtree Holdings Limited (ASX:BMT) provides AI decision support and data insights solutions for hospitals and pathology laboratories. The company combines clinical, coding and data expertise.

FY26 Strategy and Product Focus

Beamtree refined its product portfolio around Rippledown, PICQ, PICQ Audit, RISQ and analytics platforms. The company also launched Autonomous Coding Solutions and Autonomous Data Entry.

Operational Changes and Outlook

The company simplified operations, strengthened Leadership and focused Investment on products with customer Demand and innovation potential.

Key Insights

Beamtree is advancing healthcare AI solutions through focused product development and Recurring Revenue growth.